Udo Kraushaar

Dr. Udo Kraushaar

Next-Generation Cellular and Organotypic Assays, NMI Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Baden-Württemberg, Germany
orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2012 in Frontiers in Neuroengineering
Verified
Journal Article
Open access
RGRamona Gerwig
Ramona Gerwig
KFKai Fuchsberger
Kai Fuchsberger
BSBirgit Schroeppel
Birgit Schroeppel
GLGordon Steve Link
Gordon Steve Link
GHGerhard Heusel
Gerhard Heusel
MSMartin Stelzle
Martin Stelzle
Composites of carbon nanotubes and poly(3,4-ethylenedioxythiophene, PEDOT) and layers of PEDOT are deposited onto microelectrodes by electropolymerization of ethylenedioxythiophene in the presence of a suspension of carbon nanotubes and polystyrene sulfonate. Analysis by FIB and SEM demonstrates that CNT–PEDOT composites exhibit a porous morphology whereas PEDOT layers are more compact. Accordingly, capacitance and charge injection capacity of the composite material exceed those of pure PEDOT layers. In vitro cell culture experiments reveal excellent biocompatibility and adhesion of both PEDOT and PEDOT–CNT electrodes. Signals recorded from heart muscle cells demonstrate the high S/N ratio achievable with these electrodes. Long-term pulsing experiments confirm stability of charge injection capacity. In conclusion, a robust fabrication procedure for composite PEDOT–CNT electrodes is demonstrated and results show that these electrodes are well suited for stimulation and recording in cardiac and neurophysiological research.

22 November 2011 in Expert Opinion on Drug Safety
Verified
Journal Article
Closed access
Udo KraushaarUdo Kraushaar
Udo Kraushaar
TMThomas Meyer
Thomas Meyer
DHDietmar Hess
Dietmar Hess
LGLior Gepstein
Lior Gepstein
CMChristine L Mummery
Christine L Mummery
EGElke Guenther
Elke Guenther
Introduction: The field of cardiac safety pharmacology has been experiencing exciting changes over the recent years. Drug induced arrhythmia of the torsade des pointes types has been the reason for the denial of approval of novel drug candidates. The aim of cardiac safety pharmacology is to detect undesirable pharmacodynamic drug effects within and above the therapeutic range. A special focus is on the identification of potential arrhythmogenic effects within the drug discovery chain. Areas covered: Here, the authors discuss the relevance of induced pluripotent stem (iPS) cell derived cardiomyocytes for safety pharmacology. The technology of obtaining functional cardiomyocytes from somatic cells of healthy donors and patients with inherited diseases is the basis for diverse disease models in multi-level safety pharmacology screening. The reader will gain an overview of stem cell based technologies in cardiac safety pharmacology in cardiac and disease modeling by iPS cell derived cardiomyocytes from patients with an inherited cardiac syndrome. Expert opinion: iPS cell derived cardiomyocytes – especially from patients with increased risk of cardiac arrhythmia – are on the verge of offering new options for drug testing. More reliable assays can be expected to predict the arrhythmogenic risk of drug candidates in humans. However, this technology is still new and extensive validation studies are due.

1 January 2024 in Tissue Engineering Part A
Verified
Journal Article
Closed access
JKJasmin Knoll
Jasmin Knoll
BABastian Amend
Bastian Amend
NHNiklas Harland
Niklas Harland
SISimon Isser
Simon Isser
NBNicolas Beziere
Nicolas Beziere
Wilhelm AicherWilhelm Aicher
Wilhelm Aicher
The leading cause of stress urinary incontinence in women is the urethral sphincter muscle deficiency caused by mechanical stress during pregnancy and vaginal delivery. In men, prostate cancer surgery and injury of local nerves and muscles are associated with incontinence. Current treatment often fails to satisfy the patient's needs. Cell therapy may improve the situation. We therefore investigated the regeneration potential of cells in ameliorating sphincter muscle deficiency and urinary incontinence in a large animal model. Urethral sphincter deficiency was induced surgically in gilts by electrocautery and balloon dilatation. Adipose tissue-derived stromal cells and myoblasts from Musculus semitendinosus were isolated from male littermates, expanded, characterized in depth for expression of marker genes and in vitro differentiation, and labelled. The cells were injected into the deficient sphincter complex of the incontinent female littermates. Incontinent gilts receiving no cell therapy served as controls. Sphincter deficiency and functional regeneration were recorded by monitoring the urethral wall pressure during follow-up by two independent methods. Cells injected were detected in vivo during follow-up by transurethral fluorimetry, ex vivo by fluorescence imaging, and in cryosections of tissues targeted by immunofluorescence and by PCR of the SRY gene. Partial spontaneous regeneration of sphincter muscle function was recorded in control gilts, but the sphincter function remained significantly below levels measured prior to induction of incontinence (67.03±14.00%, n=6, p<0.05). Injection of myoblasts yielded an improved sphincter regeneration within five weeks of follow-up but did not reach significance compared to control gilts (81.54±25.40%, n=5). A significant and full recovery of the urethral sphincter function was observed upon injection of adipose tissue-derived mesenchymal stromal cells within five weeks of follow-up (100.4±23.13%, n=6, p<0.05). Injection of stromal cells provoked slightly stronger infiltration of CD45pos leukocytes compared to myoblasts injections and controls. The data of this exploratory study indicate that adipose tissue-derived mesenchymal stromal cells inherit a significant potential to regenerate the function of the urethral sphincter muscle.

13 September 2022 in Journal of Visualized Experiments
Verified
Journal Article
Closed access
PDF file
JSJasmin Schaefer
Jasmin Schaefer
TDTimm Danker
Timm Danker
KGKarin Gebhardt
Karin Gebhardt
Udo KraushaarUdo Kraushaar
Udo Kraushaar
Life-threatening drug-induced cardiac arrhythmia is often preceded by prolonged cardiac action potentials (AP), commonly accompanied by small proarrhythmic membrane potential fluctuations. The shape and time course of the repolarizing fraction of the AP can be pivotal for the presence or absence of arrhythmia. Microelectrode arrays (MEA) allow easy access to cardiotoxic compound effects via extracellular field potentials (FP). Although a powerful and well-established tool in research and cardiac safety pharmacology, the FP waveform does not allow to infer the original AP shape due to the extracellular recording principle and the resulting intrinsic alternating current (AC) filtering. A novel device, described here, can repetitively open the membrane of cardiomyocytes cultivated on top of the MEA electrodes at multiple cultivation time points, using a highly focused nanosecond laser beam. The laser poration results in transforming the electrophysiological signal from FP to intracellular-like APs (laser-induced AP, liAP) and enables the recording of transcellular voltage deflections. This intracellular access allows a better description of the AP shape and a better and more sensitive classification of proarrhythmic potentials than regular MEA recordings. This system is a revolutionary extension to the existing electrophysiological methods, permitting accurate evaluation of cardiotoxic effect with all advantages of MEA-based recordings (easy, acute, and chronic experiments, signal propagation analysis, etc.).


30 August 2023 in Biomedical Microdevices
Verified
Journal Article
Closed access
PDF file
DPDomenic Pascual
Domenic Pascual
LBLisa Brauns
Lisa Brauns
RDRuth Domes
Ruth Domes
MTMatthias Tisler
Matthias Tisler
MKMarco Kögel
Marco Kögel
PJPeter D. Jones
Peter D. Jones